Benjamin F. Edwards & Company, Inc. Abbott Laboratories Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 262,366 shares of ABT stock, worth $30.8 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
262,366
Previous 248,522
5.57%
Holding current value
$30.8 Million
Previous $28.2 Million
3.48%
% of portfolio
0.48%
Previous 0.51%
Shares
28 transactions
Others Institutions Holding ABT
# of Institutions
3,185Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.7 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15.4 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.72 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.26 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $206B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...